My Thoughts and Expressions
India has stood out as a resilient economy that has weathered the headwinds of global macroeconomic dynamics of inflation, recession and supply chain disruptions. India must leverage its economic momentum to drive a projected 6.5-7% GDP growth in FY24. This year’s Budget therefore ought to lay the framework to deliver on this potential. This will … Continue reading Budget 2023 can Boost India’s March to Global Leadership in Research & Innovation
The Indian economy has been resilient amidst a challenging global macroeconomic scenario of inflation, recession and supply chain disruptions, with GDP projected to grow 6.5-7% in FY24. This year’s Budget therefore ought to lay the framework to deliver on this potential. Budget Should Focus on Research & Innovation For India to deliver on its aspiration … Continue reading Budget 2023 can Lay the Groundwork for India to Assume Leadership in Research & Innovation
John Shaw and Kiran Mazumdar-Shaw, who are the principal donors to the University of Glasgow’s £116 million flagship research facility, the Mazumdar Shaw Advanced Research Centre (ARC), visited the completed building for the first time on August 11, 2022. The Advanced Research Centre Building John and Kiran donated $7.5 million to the University of Glasgow … Continue reading John Shaw and Kiran Mazumdar-Shaw, Principal Donors to Mazumdar Shaw ARC, University of Glasgow, Visit New Research Facility for the First Time
By Kiran Mazumdar-Shaw The aftermath of the COVID-19 pandemic and the ongoing Russia-Ukraine war have triggered massive disruptions in global supply chains, revealing the vulnerability of networks that were largely built on cost optimisation. Supply chains are critical to global growth, so their reinvention is vital to rebuilding economies in the post pandemic world. A … Continue reading Reinventing Supply Chains of Tomorrow
By Kiran Mazumdar-Shaw Over the last 20 years, life sciences in India has gone from being a nascent sector to a sunrise industry. When I began my own entrepreneurial journey in 1978, little did I know that I was sowing the seeds of the country’s biotechnology revolution. Up until the mid-1980s, I was the lone … Continue reading India’s Life Sciences Industry Poised for the Next Level
By Kiran Mazumdar-Shaw, Executive Chairperson, Biocon & Biocon Biologics The tectonic shifts that the COVID-19 pandemic brought with it has thrust the Indian biotechnology industry into the global limelight. The industry responded with grit, agility and creativity to address India’s healthcare needs in the face of a rampaging viral outbreak. This global emergency galvanized India’s … Continue reading The Pandemic has Unleashed Opportunities We Never Thought Existed
Kiran Mazumdar-Shaw, Executive Chairperson, Biocon and Biocon Biologics, spoke at the India Global Forum (IGF) organized in Bengaluru to celebrate 75 years of Independence and to showcase the very best of the ‘New India Inc.’ The session titled "Inspiring Journeys with Ms Kiran Mazumdar-Shaw" was moderated by Edie Lush who is an award-winning journalist, author, … Continue reading Inspiring Journeys with Ms Kiran Mazumdar-Shaw
Biocon Biologics on Monday announced a transformational deal to acquire partner Viatris’ global biosimilars business for up to USD 3.335 billion in cash and stock. The acquisition of the business, which is estimated to generate revenues of USD 1 billion next year, will create a unique, fully integrated global biosimilars enterprise. Kiran Mazumdar-Shaw, Executive Chairperson, … Continue reading A game-changing, transformational deal that is an inflection point in Biocon Biologic’s journey of making global impact: Kiran Mazumdar-Shaw
Biocon Biologics on Monday announced a transformational deal to acquire partner Viatris’ global biosimilars business for up to USD 3.335 billion in cash and stock. The acquisition of the business, which is estimated to generate revenues of USD 1 billion next year, will create a unique, fully integrated global biosimilars enterprise. Kiran Mazumdar-Shaw, Executive Chairperson, … Continue reading The Biocon Biologics-Viatris Transaction Catapults us into The Global Big League
Biocon Biologics on Monday announced a transformational deal to acquire partner Viatris’ global biosimilars business for up to USD 3.335 billion in cash and stock. The acquisition of the business, which is estimated to generate revenues of USD 1 billion next year, will create a unique, fully integrated global biosimilars enterprise. Kiran Mazumdar-Shaw, Executive Chairperson, … Continue reading It’s a win-win transaction. It catapults us into the global big league: Kiran Mazumdar-Shaw